๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Combined hepatitis B immune globulin and vaccine for postexposure prophylaxis of hepatitis B virus infection

โœ Scribed by Yoshihiro Akahane; Fumio Tsuda; Makoto Mayumi


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
120 KB
Volume
10
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Review: hepatitis B immune globulin for
โœ J.N. Zuckerman ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB

## Abstract Specific hepatitis B immune globulin (HBIG) contains a high titer of antibody to hepatitis B surface antigens and provides immediate passive protection against infection with hepatitis B virus, after acute exposure to infection. It is now generally combined with active immunization with

Hepatitis B virus envelope variation aft
โœ W F Carman; C Trautwein; J van Deursen; K Colman; E Dornan; G McIntyre; J Waters ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 249 KB ๐Ÿ‘ 1 views

cleoside analogues, 8-10 the only established treatment option Hepatitis B virus (HBV) replicates via an intermediate to prevent reinfection is the administration of polyclonal hep-RNA step. High frequency of polymerase errors with adatitis B surface antigen antibody (anti-HBs) (hepatitis B imdition

Intramuscular hepatitis B immune globuli
โœ Yao, Francis Y. ;Osorio, Robert W. ;Roberts, John P. ;Poordad, Fred F. ;Briceno, ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 59 KB

Immunoprophylaxis using intravenous (IV) hepatitis B immune globulin (HBIG) decreases the recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). However, IV HBIG is expensive, has significant side effects, and is inconvenient to administer. An alternative appro

Prophylaxis against hepatitis B recurren
โœ Jay S. Markowitz; Paul Martin; Andrew J. Conrad; James F. Markmann; Philip Seu; ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 52 KB

Patients undergoing liver transplantation for hepatitis B-related liver disease are prone to recurrence. The mainstay of prophylaxis has been passive immunotherapy with hepatitis B immune globulin (HBIG). Antiviral therapy with lamivudine has proven effective in lowering hepatitis B virus (HBV) DNA

Liver transplantation for chronic hepati
โœ Yoshida, Eric M. ;Erb, Siegfried R. ;Partovi, Nilufar ;Scudamore, Charles H. ;Ch ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 71 KB ๐Ÿ‘ 1 views

Current protocols for prophylaxis against allograft reinfection after liver transplantation for chronic hepatitis B virus (HBV) infection include the administration of large doses of hepatitis B immune globulin (HBIG), with considerable associated economic costs. Monotherapeutic prophylaxis with lam